Literature DB >> 26824652

Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.

Cherie T Ng1, Juan L Mendoza2, K Christopher Garcia2, Michael B A Oldstone3.   

Abstract

Type I interferon (IFN-I) elicits a complex cascade of events in response to microbial infection. Here, we review recent developments illuminating the large number of IFN-I species and describing their unique biologic functions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bacterial infection; interferon alpha-beta receptor; interferon-alpha; interferon-beta; pathogenesis; persistent viral infection; type 1 interferon

Mesh：

Substances：

Year:  2016        PMID： 26824652      PMCID： PMC4733246          DOI： 10.1016/j.cell.2015.12.027

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  31 in total

1.  Systematic identification of type I and type II interferon-induced antiviral factors.

Authors:  Su-Yang Liu; David Jesse Sanchez; Roghiyh Aliyari; Sun Lu; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 2.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

Review 3.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

4.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

5.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Sandra D Oland; Eduardo P Amaral; Daniel L Barber; Jacqueline Gonzales; Steven C Derrick; Ruiru Shi; Nathella Pavan Kumar; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Subash Babu; Marta Catalfamo; Andres M Salazar; Laura E Via; Clifton E Barry; Alan Sher
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

7.  Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus.

Authors:  Kirsten Schneider; Andrea Loewendorf; Carl De Trez; James Fulton; Antje Rhode; Heather Shumway; Sukwon Ha; Ginelle Patterson; Klaus Pfeffer; Sergei A Nedospasov; Carl F Ware; Chris A Benedict
Journal:  Cell Host Microbe       Date:  2008-02-14       Impact factor: 21.023

8.  Early virus-host interactions dictate the course of a persistent infection.

Authors:  Brian M Sullivan; John R Teijaro; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

9.  Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease.

Authors:  Frederick J Schnell; Sarah Sundholm; Stacy Crumley; Patrick L Iversen; Dan V Mourich
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307
View more
  55 in total

1.  A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.

Authors:  Kapil Saxena; Lukas M Simon; Xi-Lei Zeng; Sarah E Blutt; Sue E Crawford; Narayan P Sastri; Umesh C Karandikar; Nadim J Ajami; Nicholas C Zachos; Olga Kovbasnjuk; Mark Donowitz; Margaret E Conner; Chad A Shaw; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

2.  Innate Immune Responses and Pulmonary Diseases.

Authors:  Tao Liu; Siqi Liu; Xiaobo Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.

Authors:  Wei Zhang; Seong-Min Lim; Juyoung Hwang; Srinivasan Ramalingam; Myunghee Kim; Jun-O Jin
Journal:  Cancer Immunol Immunother       Date:  2020-09-09       Impact factor: 6.968

4.  Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection.

Authors:  Monica Macal; Yeara Jo; Simone Dallari; Aaron Y Chang; Jihong Dai; Shobha Swaminathan; Ellen J Wehrens; Patricia Fitzgerald-Bocarsly; Elina I Zúñiga
Journal:  Immunity       Date:  2018-04-17       Impact factor: 31.745

5.  NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects.

Authors:  Emmanouil Papasavvas; Livio Azzoni; Andrew V Kossenkov; Noor Dawany; Knashawn H Morales; Matthew Fair; Brian N Ross; Kenneth Lynn; Agnieszka Mackiewicz; Karam Mounzer; Pablo Tebas; Jeffrey M Jacobson; Jay R Kostman; Louise Showe; Luis J Montaner
Journal:  J Immunol       Date:  2019-06-28       Impact factor: 5.422

6.  Interferon-β acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation.

Authors:  Francisco Fueyo-González; Mitchell McGinty; Mehek Ningoo; Lisa Anderson; Chiara Cantarelli; Markus Demir; Inés Llaudó; Carolina Purroy; Nada Marjanovic; David Heja; Stuart C Sealfon; Peter S Heeger; Paolo Cravedi; Miguel Fribourg
Journal:  Immunity       Date:  2022-02-10       Impact factor: 31.745

Review 7.  Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.

Authors:  Juliet M Taylor; Zachery Moore; Myles R Minter; Peter J Crack
Journal:  J Neural Transm (Vienna)       Date:  2017-07-04       Impact factor: 3.575

8.  Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection.

Authors:  Ronghua Hu; Chang-Qing Xia; Edward Butfiloski; Michael Clare-Salzler
Journal:  Clin Immunol       Date:  2018-06-09       Impact factor: 3.969

9.  Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist.

Authors:  Caleb R Glassman; Leon Su; Sonia S Majri-Morrison; Hauke Winkelmann; Fei Mo; Peng Li; Magdiel Pérez-Cruz; Peggy P Ho; Ievgen Koliesnik; Nadine Nagy; Tereza Hnizdilova; Lora K Picton; Marek Kovar; Paul Bollyky; Lawrence Steinman; Everett Meyer; Jacob Piehler; Warren J Leonard; K Christopher Garcia
Journal:  Elife       Date:  2021-05-18       Impact factor: 8.140

Review 10.  Interferon target-gene expression and epigenomic signatures in health and disease.

Authors:  Franck J Barrat; Mary K Crow; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.